TSN is known to be one of the components of RISC (RNA-induced silencing complex) and is involved in RNA interference and miRNA-mediated target regulation [12–14]; therefore, we investigated whether the effect of TSN silencing on NSCLC sensitivity to cisplatin is related to TSN functioning as a part of the RISC complex. This evidence concerns the gene TSN and non-small cell lung carcinoma.